+29.3%
CIFR vs CVS
+31.0%
-1.7%
-97.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -8.7% | -0.7% | -8.0% | -8.6% |
| 7D | +11.3% | -1.9% | +13.2% | +11.8% |
| 30D | +3.5% | -0.3% | +3.8% | +3.4% |
| 3M | -26.6% | -1.1% | -25.5% | -26.6% |
| 6M | +18.1% | +23.7% | -5.6% | +11.8% |
| YTD | +14.5% | +23.0% | -8.5% | +6.9% |
| 1Y | +83.3% | +37.2% | +46.1% | +66.3% |
| 3Y | +461.5% | +62.4% | +399.0% | +401.3% |
| 5Y | +29.3% | +31.8% | -2.5% | -7.2% |
| All | +29.3% | +31.0% | -1.7% | -7.2% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling